Valuation: ResMed, Inc.

Capitalization 36.67B 31.62B 28.54B 27.39B 49.94B 3,370B 52.27B 337B 135B 1,616B 138B 135B 5,781B P/E ratio 2026 *
23.9x
P/E ratio 2027 * 21.4x
Enterprise value 35.61B 30.7B 27.72B 26.59B 48.49B 3,272B 50.75B 328B 131B 1,569B 134B 131B 5,613B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 5.74x
Free-Float
76.64%
Yield 2026 *
0.96%
Yield 2027 * 1.07%
1 day-0.96%
1 week-1.32%
Current month-1.32%
1 month-6.91%
3 months-1.43%
6 months-8.73%
Current year+4.98%
1 week 248.13
Extreme 248.13
260.22
1 month 245.65
Extreme 245.6475
277.67
Current year 240
Extreme 240
277.67
1 year 199.92
Extreme 199.92
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 55.13
Extreme 55.13
301.34
Manager TitleAgeSince
Chief Executive Officer 53 2013-02-28
Director of Finance/CFO 59 2005-12-31
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 53 2023-01-24
Chairman 83 1989-05-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.96%-1.32%+12.37%+15.38% 36.84B
-3.25%-3.67%-4.87%-10.12% 186B
-1.32%-2.65%-8.99%+108.71% 174B
-3.22%-7.19%-8.99%-21.75% 138B
-2.25%-7.16%-29.22%+49.46% 106B
-0.22%-4.11%-23.32%-20.20% 52.29B
-2.68%-5.59%+13.70%+3.60% 47.42B
-3.68%-11.87%-13.04%-3.14% 33.85B
-2.57%-5.20%-9.07%-19.66% 32.52B
+2.93%-2.45%-26.67%-42.06% 31.81B
Average -1.72%-3.96%-9.81%+6.02% 83.94B
Weighted average by Cap. -2.15%-3.88%-10.13%+20.09%

Financials

2026 *2027 *
Net sales 5.64B 4.87B 4.39B 4.21B 7.69B 519B 8.04B 51.93B 20.8B 249B 21.18B 20.73B 890B 6.07B 5.23B 4.72B 4.53B 8.26B 558B 8.65B 55.82B 22.36B 267B 22.77B 22.28B 956B
Net income 1.54B 1.33B 1.2B 1.15B 2.1B 142B 2.2B 14.19B 5.68B 67.97B 5.79B 5.66B 243B 1.73B 1.49B 1.34B 1.29B 2.35B 159B 2.46B 15.87B 6.36B 76.03B 6.48B 6.34B 272B
Net Debt -1.07B -919M -830M -796M -1.45B -97.95B -1.52B -9.81B -3.93B -46.97B -4B -3.91B -168B -1.87B -1.62B -1.46B -1.4B -2.55B -172B -2.67B -17.23B -6.9B -82.55B -7.03B -6.88B -295B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
26-03-06 252.87 $ -0.96% 920,796
26-03-05 255.32 $ -1.44% 865,475
26-03-04 259.05 $ +0.30% 664,356
26-03-03 258.28 $ +0.35% 1,229,270
26-03-02 257.39 $ +0.44% 951,647
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
252.87USD
Average target price
297.47USD
Spread / Average Target
+17.64%

Quarterly revenue - Rate of surprise